Welcome to
On Feet Nation
Posted by mulfy on February 22, 2025 at 8:34pm 0 Comments 0 Likes
dPCR and qPCR market growth is driven mainly by the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project.
The global dPCR and qPCR market size is projected to reach $7.6 billion by 2025 from $4.9 billion in 2020, at a CAGR of 9.0%.
North America accounted for the largest share of the global dPCR and qPCR market, followed by North America. The large share of the North American Digital PCR Market is attributed to the increased adoption of innovative and novel genomic analysis products (including advanced qPCR and dPCR products), availability of R&D funding for genomic research (coupled with the robust research infrastructure in the region), expanding use of PCR techniques in clinical diagnostics & forensics, and early commercialization of qPCR/dPCR products compared to other regions.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204
Digital PCR (dPCR) and Real-time PCR (qPCR) - Market- Report Highlights
OPPORTUNITY: Growing market penetration in emerging countries
Emerging markets are expected to offer significant growth opportunities due to the rising incidence of infectious and chronic diseases as well as increasing R&D initiatives to develop innovative genomic techniques such as qPCR and dPCR. The growth in these dPCR and qPCR market is supported by the expansion of healthcare infrastructure, increase in healthcare expenditure, and reducing procedural costs for qPCR and dPCR-based disease diagnosis. Emerging countries are witnessing rapid modernization in healthcare facilities and the expansion of healthcare infrastructure. This factor is contributing to the growing demand for clinical diagnostic procedures among diagnostic laboratories, which is resulting in the increased sales of clinical qPCR and dPCR products.
Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland) are the key players operating in this market.
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global dPCR and qPCR market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the dPCR and qPCR market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Browse in-depth TOC on "Digital PCR Market"
253 – Tables
41 – Figures
316 – Pages
https://www.marketsandmarkets.com/Market-Reports/digital-pcr-market...
© 2025 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation